The Gaithersburg biotech, which also detailed changes to a U.K. sales agreement for its Covid vaccine, saw its share price drop in after-hours trading.
{iframe}https://www.bizjournals.com/washington/news/2022/12/14/novavax-proposes-125m-separate-stock-debt-offering.html?utm_source=st&utm_medium=en&utm_campaign=BN&utm_content=wa&ana=e_wa_BN&j=29985042&senddate=2022-12-14{/iframe}